H.R. 9471

H.R. 9471: To create protections for financial institutions that provide financial services to State-sanctioned marijuana businesses and service providers for such businesses, and for other purposes.

Introduced David Joyce (R) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 9471 aims to create legal protections for financial institutions that offer financial services to marijuana businesses that are sanctioned by state law. This would help these businesses access banking services, which they often struggle to do due to federal regulations that classify marijuana as an illegal substance.

Positive Media Summary

Supporters of H.R. 9471 highlight the bill as a crucial step towards normalizing the marijuana industry and ensuring that state-sanctioned businesses can operate more effectively. They argue that it will enhance public safety by allowing these businesses to use banks instead of cash, reducing the risks associated with handling large amounts of money.

Negative Media Summary

Critics of H.R. 9471 express concerns about the potential implications of further normalizing the marijuana industry, particularly regarding federal law and the ongoing debate over legalization. Some argue that this bill could undermine efforts to enforce drug laws and may send mixed messages about the federal government's stance on marijuana.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Finance and Financial Sector

The analysis of H.R. 9471, aimed at providing protections for financial institutions servicing state-sanctioned marijuana businesses, reveals no direct overlaps between the sponsor David Joyce's top donor industries and the bill's subject matter. The top donors primarily come from sectors such as energy, biotechnology, and healthcare, which do not have a direct financial interest in the marijuana industry. The lobbying activity in this area shows significant contributions from companies like Occidental Petroleum Corporation ($20,000) and Ginkgo Bioworks, Inc. ($60,000), but these industries are not aligned with the interests of marijuana businesses. Therefore, while there is some lobbying activity, it does not present a clear conflict of interest for the sponsor regarding this specific legislation.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
RESPOND-US CORNERSTONE GOVERNMENT AFFAIRS, INC. $140,000
SILVERLINING ALPINE GROUP PARTNERS, LLC. $80,000
MEDLINE CORNERSTONE GOVERNMENT AFFAIRS, INC. $80,000
GINKGO BIOWORKS, INC. CORNERSTONE GOVERNMENT AFFAIRS, INC. $60,000
AMERICAN FLOOD COALITION ACTION INC ALPINE GROUP PARTNERS, LLC. $60,000
PEABODY ENERGY CORPORATION CORNERSTONE GOVERNMENT AFFAIRS, INC. $50,000
LUFTHANSA GERMAN AIRLINES CAPITOL POINT GROUP, LLC $50,000
MERIDIAM INFRASTRUCTURE CAPITOL POINT GROUP, LLC $40,000
TULANE UNIVERSITY LEWIS-BURKE ASSOCIATES, LLC $40,000
LEO TECHNOLOGIES BUTLER SNOW LLP $30,000
MAXIMUS BRICK STREET STRATEGY $30,000
JOHNSON & JOHNSON BRICK STREET STRATEGY $30,000
OCCIDENTAL PETROLEUM CORPORATION GTB PARTNERS $20,000
HEARTH, PATIO & BARBECUE ASSOCIATION HEARTH, PATIO & BARBECUE ASSOCIATION $15,000
BASIS PATH BUTLER SNOW LLP undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding David Joyce, ranked by total contributions.

Health Professionals $600,000,000
Individuals: $600,000,000 PACs: $0
Retired $187,500,000
Individuals: $187,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us